drugset
drugset / Trial / NCT02405104

Chlorzoxazone in Hip and Knee Arthroplasty

NCT02405104 ↗

Phase 4 Completed 400 enrolled Northern Orthopaedic Division, Denmark
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to elucidate whether patients operated with THA and TKA can benefit from treatment with chlorzoxazone.

Timeline

Start
2015-09-01
Primary completion
2017-12-31
Completion
2019-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorzoxazone Small molecule 250 mg —

Indications

osteoarthritis, hip osteoarthritis, knee